NCT01548612View on ClinicalTrials.gov

Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

June 30, 2009

Study Completion Date

December 31, 2010

Conditions
Schizophrenia
Interventions
DRUG

Sodium nitroprusside

Intravenous infusion of 0,5 mcg/kg/min for 240 minutes

DRUG

Glucose solution

Intravenous infusion of glucose solution 5% for 240 minutes

Trial Locations (1)

14048-900

University General Hospital of the Ribeirao Preto Medical School, Ribeirão Preto

All Listed Sponsors
lead

University of Sao Paulo

OTHER

NCT01548612 - Add-on Sodium Nitroprusside to Treatment as Usual in Schizophrenia | Biotech Hunter | Biotech Hunter